Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 321

1.

Influence of H. pylori infection and eradication on p53, c-erbB-2 and Ki-67 in gastric mucosa.

Brajsa K, Ferencic Z, Katicic M, Radosevic S, Presecki V, Spaventi R, Dominis M.

Hepatogastroenterology. 2006 Nov-Dec;53(72):968-72.

PMID:
17153465
2.

Influence of Helicobacter pylori infection persistence on bcl-2 expression in gastric mucosa inflammatory cells.

Brajsa K, Ferencić Z, Katicić M, Bosnjak B, Presecki V, Spaventi R, Dominis M.

Acta Clin Croat. 2008 Sep;47(3):123-7.

PMID:
19175059
3.

Enhanced cellular proliferation and p53 accumulation in gastric mucosa chronically infected with Helicobacter pylori.

Hibi K, Mitomi H, Koizumi W, Tanabe S, Saigenji K, Okayasu I.

Am J Clin Pathol. 1997 Jul;108(1):26-34.

PMID:
9208975
4.

p53 expression in the gastric mucosa before and after eradication of Helicobacter pylori.

Satoh K, Kihira K, Kawata H, Tokumaru K, Kumakura Y, Ishino Y, Kawakami S, Inoue K, Kojima T, Satoh Y, Mutoh H, Sugano K.

Helicobacter. 2001 Mar;6(1):31-6.

PMID:
11328363
5.

Helicobacter pylori infection affects the expression of PCNA, p53, c-erbB-2 and Bcl-2 in the human gastric mucosa.

Jorge O, Cuello Carrión FD, Jorge A, Ciocca DR.

Rev Esp Enferm Dig. 2003 Feb;95(2):97-104, 89-96. English, Spanish.

PMID:
12760717
6.

Impact of bacterial eradication on the cell proliferation and p53 protein accumulation in Helicobacter pylori-associated gastritis.

Hsu PI, Lai KH, Chien EJ, Lin CK, Lo GH, Jou HS, Cheng JS, Chan HH, Hsu JH, Ger LP, Hsu PN, Tseng HH.

Anticancer Res. 2000 Mar-Apr;20(2B):1221-8.

PMID:
10810425
7.
8.

gammadelta T cells increase with gastric mucosal interleukin (IL)-7, IL-1beta, and Helicobacter pylori urease specific immunoglobulin levels via CCR2 upregulation in Helicobacter pylori gastritis.

Futagami S, Hiratsuka T, Suzuki K, Kusunoki M, Wada K, Miyake K, Ohashi K, Shimizu M, Takahashi H, Gudis K, Kato S, Tsukui T, Sakamoto C.

J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 1):32-40.

PMID:
16706809
9.

Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.

Pimanov SI, Makarenko EV, Voropaeva AV, Matveenko ME, Voropaev EV.

J Gastroenterol Hepatol. 2008 Nov;23(11):1666-71. Epub 2007 Jun 7.

PMID:
17559360
10.

Expression of cell-cycle related proteins in Helicobacter pylori gastritis and association with gastric carcinoma.

Polat A, Cinel L, Dusmez D, Aydin O, Egilmez R.

Neoplasma. 2002;49(2):95-100.

PMID:
12088113
11.

[The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].

Walecka-Kapica E, Knopik-Dabrowicz A, Klupińska G, Chojnacki J.

Pol Merkur Lekarski. 2008 Feb;24(140):95-100. Polish.

PMID:
18634262
12.

[Effect of Helicobacter pylori infection and eradication on proliferative kinetics of the gastric mucosa].

Unger Z, Prónai L, Szaleczky E, Zágoni T, Molnár B, Tulassay Z.

Orv Hetil. 2000 Dec 10;141(50):2695-700. Hungarian.

PMID:
11189675
13.

Effect of Helicobacter pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis.

Nardone G, Staibano S, Rocco A, Mezza E, D'armiento FP, Insabato L, Coppola A, Salvatore G, Lucariello A, Figura N, De Rosa G, Budillon G.

Gut. 1999 Jun;44(6):789-99. Erratum in: Gut 2000 Apr;46(4):584.

14.

Enhanced levels of C-X-C chemokine, human GROalpha, in Helicobacter pylori-associated gastric disease.

Suzuki H, Mori M, Sakaguchi AA, Suzuki M, Miura S, Ishii H.

J Gastroenterol Hepatol. 1998 May;13(5):516-20.

PMID:
9641651
15.

Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.

Shun CT, Wu MS, Lin JT, Chen SY, Wang HP, Lee WJ, Wang TH, Chuang SM.

Hepatogastroenterology. 1997 Mar-Apr;44(14):604-9.

PMID:
9164544
16.
17.

Histopathology and expression of Ki-67 and cyclooxygenase-2 in childhood Helicobacter pylori gastritis.

Kim KM, Oh YL, Ko JS, Choe YH, Seo JK.

J Gastroenterol. 2004;39(3):231-7.

PMID:
15064999
18.

Immunohistochemical evaluation of p53 expression and proliferative activity in children with Helicobacter pylori associated gastritis.

Ozturk Y, Ozer E, Lebe B, Bekem O, Buyukgebiz B.

J Pediatr Gastroenterol Nutr. 2005 Apr;40(4):467-70.

PMID:
15795596
19.

Assessment of p21, p53 expression, and Ki-67 proliferative activities in the gastric mucosa of children with Helicobacter pylori gastritis.

Saf C, Gulcan EM, Ozkan F, Cobanoglu Saf SP, Vitrinel A.

Eur J Gastroenterol Hepatol. 2015 Feb;27(2):155-61. doi: 10.1097/MEG.0000000000000246.

PMID:
25533430
20.

Effect of Helicobacter pylori infection on ghrelin expression in human gastric mucosa.

Tatsuguchi A, Miyake K, Gudis K, Futagami S, Tsukui T, Wada K, Kishida T, Fukuda Y, Sugisaki Y, Sakamoto C.

Am J Gastroenterol. 2004 Nov;99(11):2121-7.

PMID:
15554990

Supplemental Content

Support Center